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Abstract
Objectives—Among hospice patients who lived in nursing homes, we sought to: (1) report
trends in hospice use over time, (2) describe factors associated with very long hospice stays (>6
months), and (3) describe hospice utilization patterns.
Design, setting, and participants—We conducted a retrospective study from an urban,
Midwest cohort of hospice patients, aged ≥65 years, who lived in nursing homes between 1999
and 2008.
Measurements—Demographic data, clinical characteristics, and health care utilization were
collected from Medicare claims, Medicaid claims, and Minimum Data Set assessments. Patients
with overlapping nursing home and hospice stays were identified. χ2 and t tests were used to
compare patients with less than or longer than a 6-month hospice stay. Logistic regression was
used to model the likelihood of being on hospice longer than 6 months.
Results—A total of 1452 patients received hospice services while living in nursing homes. The
proportion of patients with noncancer primary hospice diagnoses increased over time; the mean
length of hospice stay (114 days) remained high throughout the 10-year period. More than 90% of
all patients had 3 or more comorbid diagnoses. Nearly 20% of patients had hospice stays longer
than 6 months. The hospice patients with stays longer than 6 months were observed to have a
smaller percentage of cancer (25% vs 30%) as a primary hospice diagnosis. The two groups did
not differ by mean cognitive status scores, number of comorbidities, or activities of daily living
impairments. The greater than 6 months group was much more likely to disenroll before death:
33.9% compared with 13.8% (P < .0001). A variety of patterns of utilization of hospice across
settings were observed; 21 % of patients spent some of their hospice stay in the community.
Conclusions—Any policy proposals that impact the hospice benefit in nursing homes should
take into account the difficulty in predicting the clinical course of these patients, varying
utilization patterns and transitions across settings, and the importance of supporting multiple
approaches for delivery of palliative care in this setting.
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In the United States, about 1.5 million people live in nursing homes, and nearly 1 in 4
Americans die in the nursing home setting.1,2 Despite quality improvement efforts by
facilities and extensive government regulations, the quality of nursing home care varies
widely.3 Palliative care, in particular, including goals of care discussions and symptom
management, has been found to be suboptimal in the nursing home setting.4–8 The Medicare
hospice benefit, which provides palliative care for terminally ill patients, is the predominant
avenue through which nursing home patients receive specialized end-of-life care services.
Hospice has been demonstrated to improve quality of care outcomes for patients dying in
nursing homes, including improved pain management, reduced hospitalizations, and
improved family satisfaction.9–13
Use of the hospice benefit has grown dramatically over the past few decades: Approximately
40% of Medicare enrollees die while receiving hospice services.14–16 About one third of all
hospice patients live in nursing homes.15 On average, nursing home hospice patients tend to
have longer lengths of stay compared with hospice patients living in the community.
Patients with longer hospice stays and more clinically stable courses tend to be more
profitable to hospice providers because Medicare reimburses hospice on a per diem basis.17
Increasing attention is being focused on nursing home hospice patients because of the
growth of hospice in this setting.18 The Medicare hospice benefit is designed for patients
with terminal disease who have an anticipated life expectancy of ≤6 months. Policymakers
have expressed concern that some nursing home patients who are on hospice do not meet
these eligibility criteria.18 Nursing home hospice patients are less likely to have cancer as
their primary diagnosis and more likely to have diagnoses such as dementia.19 It can be
difficult for physicians to predict life expectancy even in the setting of advanced dementia.8
Although policymakers are concerned about overuse of hospice, advocates are concerned
about potential underuse of both hospice and palliative care services in the nursing home
setting.13
This study was undertaken to better understand the patterns of use of hospice among nursing
home patients. Using a unique dataset of more than 30,000 adults older than 65 years, we
describe patterns of nursing home hospice use over a 10-year period. In this study, we
sought to: (1) report trends in hospice use over time, (2) describe factors associated with
very long hospice stays (>6 months), and (3) describe hospice utilization patterns of older
adults who used hospice while living in nursing homes. In addition to our interest in
describing broad patterns of utilization, we hypothesized that we would see increasing
lengths of stay for nursing home hospice patients over the time period studied. Furthermore,
we hypothesized that patients with longer hospice stays would have different clinical
characteristics and hospice utilization patterns in comparison with patients with shorter
stays, which might explain these longer stays.
Methods
Overview
This study, including waiver of patient consent, was approved by the Indiana University
Purdue University— Indianapolis Institutional Review Board and the Centers for Medicare
and Medicaid Services Privacy Board. For this analysis of nursing home hospice patients,
we used a merged dataset of Medicare claims, Indiana Medicaid claims, Minimum Data Set
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(MDS), Outcome Assessment and Information Set, and the local electronic medical record
system.20 All patients included in this database had at least one clinical encounter within
Wishard Health Services, an urban public health system serving medically indigent patients
in Indianapolis. Wishard Health Services includes a 350-bed hospital and a network of 8
primary care centers in Indianapolis. It has a Senior Care program staffed by faculty in an
academic geriatric medicine program.21 Although patients were initially enrolled at
Wishard, the Medicare, Indiana Medicaid, MDS, and Outcome Assessment and Information
Set data capture the patients’ utilization for all other providers and hospitals.
Sample
Data were collected over an 11-year period (1999—2009) on 33,387 patients aged ≥65
years. Subjects who had a clinical encounter with Wishard were enrolled if they turned 65
years old at any time between 1999 and 2008 and were matched to Medicare claims by
Centers for Medicare and Medicaid Services using name, social security number, and
birthdate. Patients with hospice and nursing home overlapping episodes were identified
using Medicare and Indiana Medicaid claims and MDS assessments. To be included in the
nursing home hospice cohort, patients had to have a hospice admission date between
January 1, 1999, and December 31, 2008. Hospice length of stay was characterized as a
period of continuous hospice enrollment. For those patients with more than one episode of
nursing home care, we used only the last nursing home stay.
Data Collection
Measures collected for analysis included demographics, co-morbidities, and health care
utilization. Demographics consisted of age, sex, race/ethnicity, and Medicare/Medicaid dual
eligibility based on claims data at time of hospice enrollment. Medicare and Medicaid
International Classification of Diseases, Ninth Revision codes present in claims files at the
time of hospice enrollment were used to measure comorbidity with indicators of coronary
artery disease, congestive heart failure, hypertension, arthritis, diabetes, chronic obstructive
pulmonary disease, and stroke. Two measures of activities of daily living function and
cognitive performance were taken from the MDS assessment closest to hospice enrollment
to augment these measures of comorbidity. Primary diagnosis of the hospice stay was also
included as an independent variable. Primary hospice diagnosis categories included
dementia, failure to thrive, heart disease, lung disease, cancer, or “"other. ” Utilization,
including hospital, hospice, and nursing home use, was derived from Medicare and
Medicaid claims. Hospice stays longer than 6 months (>180 days) were a key outcome of
interest.
Analysis
After defining a nursing home hospice cohort, we examined descriptive statistics of trends
over time in hospice use and patient characteristics. For the second aim of the study, subjects
were grouped based on hospice length of stay. Nursing home hospice patients were
considered “long stay” if they were enrolled in hospice for longer than 6 months (>180 days)
versus if they were enrolled in hospice for ≤6 months (≤180 days). χ2 and t tests were used
to compare the demographic and clinical characteristics of patients in the two hospice
length-of-stay groups. Logistic regression analysis22 was used to model the likelihood of
being a long-stay hospice patient (ie. hospice length of stay > 180 days). For the third aim,
based on the start dates of the hospice claim and the nursing home stay, we sorted the
nursing home hospice cohort into groups: hospice stay completely within a nursing home
stay, enrolling in hospice in the community and then entering a nursing home, enrolling in
hospice while in a nursing home and transferring to the community, and moving from the
community to the nursing home and back to the community while on hospice. Relative
frequencies of these specific patterns were reported.
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Results
Of the 33,387 patients in the entire sample, 32% (10,556 patients) lived in a nursing home
for some period between 1999 and 2008; 11% (3771 patients) used hospice. Of the total
sample, 10,225 (31%) died during the study period. Among the patients in this sample who
ever used hospice, 39% were living in nursing homes for at least some part of their hospice
stay, resulting in a cohort of 1452 nursing home hospice patients. Approximately 40% of the
nursing home hospice patients were African-American, and three fourths were dually
eligible for Medicare and Medicaid. Overall, 71% of all nursing home hospice patients had a
noncancer hospice diagnosis. The overall mean length of stay on hospice among these
nursing home patients was 114 days (median 36 days). About 92% of all nursing home
hospice patients had 3 or more comorbid diagnoses; a high degree of cognitive and
functional impairment was also observed. Additional demographic and clinical
characteristics are presented in Table 1.
Time Trends
Cancer was the largest single category for primary hospice diagnosis throughout the 10-year
study period in the nursing home hospice cohort: 423 (29%) of the 1452 patients (Table 1).
However, the proportion of primary hospice diagnoses of cancer among nursing home
hospice patients decreased over time from 60% in 1999 to 24% in 2008. Dementia was the
next most frequent diagnosis among nursing home hospice patients (22% overall for the 10-
year period), although dementia was the most common diagnosis in 2003 and 2005. Primary
hospice diagnosis categories of failure to thrive, heart disease, and lung disease also
increased over time (Figure 1). The mean length of stay was consistent over the 10-year
study period; no upward trend was observed despite the changing patterns of primary
diagnosis. About 23% of nursing home hospice patients had hospice stays of ≤7 days.
Characteristics of Nursing Home Hospice Patients with Less Than and Greater Than 6-
Month Stays
There were 286 (19.7%) nursing home hospice patients with a hospice stay of longer than 6
months (Table 1). Nearly 48% of patients had a hospice stay shorter than 30 days. The
greater than and less than 6-month hospice stay groups differed by primary hospice
diagnoses (P = .0379). The longer than 6-month stay hospice patients were observed to have
a slightly larger percentage of dementia (25% vs 21 %), failure to thrive (13% vs 9%), and
lung disease (11% vs 7%) diagnoses; and a smaller percentage of cancer (25% vs 30%) and
other primary hospice diagnoses (19% vs 23%). Patients with hospice stays ≤6 months had
greater proportions of congestive heart failure, coronary artery disease, hypertension, and
diabetes diagnoses than long-stay hospice patients. The two groups did not differ by mean
cognitive status scores, number of comorbidities, or activities of daily living impairments.
The long-stay group had greater rates of disenrollment before death: 33.9% compared with
13.8% (P < 0.0001; Table 1).
In the multivariable analysis, having enrolled in hospice care before transfer to the nursing
home was a significant predictor of hospice use longer than 6 months (odds ratio [OR] =
5.00, 95% CI: 3.22–7.77, P < .0001; Table 2). Compared with a primary diagnosis of cancer,
hospice diagnoses of failure to thrive (OR = 2.19, 95% CI: 1.22–3.93, P = .0091), dementia
(OR = 1.88, 95% CI: 1.10–3.21, P = .0205), and lung disease (OR = 1.87, 95% CI: 1.02–
3.44, P = .0426) were also associated with long-stay hospice use. Hospitalization in the year
before enrollment in hospice was associated with a hospice stay of ≤6 months (OR = 0.60,
95% CI: 0.44–0.83, P = .0018). Demographic and clinical characteristics, including evidence
of advanced cognitive impairment (cognitive performance scale score = 5 or 6), were not
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significant independent predictors of long-stay hospice use. The estimated area under the
receiver operator characteristic curve for this model was 0.674.
Patterns of Hospice Use
Upon examination of nursing home and hospice admission/enrollment and discharge/
disenrollment dates, we identified a variety of different patterns as patients moved across
settings while also enrolled in hospice. The most common pattern (79%, n = 1142) was
patients living in a nursing home who enrolled in hospice and remained in the nursing home.
A minority (16%, n = 183) of these patients disenrolled before death. Only 39 (3%) enrolled
in hospice the day they were admitted to the nursing home. Other patients spent some time
in the community and some time in a nursing home during a continuous hospice stay (21%,
n = 310). More than half of these patients (11.5% of total nursing home hospice population,
n = 167) enrolled in hospice in the community and then entered a nursing home, where they
remained; 37 of these patients disenrolled before death. Enrolling in hospice while in a
nursing home and then being discharged to the community on hospice was the pattern for
102 (7%). Less common were patients who enrolled on hospice in the community, spent
time in a nursing home, and then were discharged to the community again (2.8%, n = 41;
Figure 2).
Nearly 18% (n = 258) of the nursing home hospice patients disenrolled from hospice before
death. Of all 258 patients who disenrolled before death, 16% died within the next 7 days,
27% died within 30 days, and 53% died by 1 year after disenrollment. Of those who
disenrolled from hospice before death, about one third was hospitalized at some point in the
year after disenrollment.
Discussion
Growing use of the Medicare hospice benefit has cast a spotlight on its role in nursing
homes and raised questions about whether it is being used appropriately in this setting.
National trends have shown that length of hospice stay has increased over time for nursing
home patients, from a mean of 46 days in 1999 to 93 days in 2006, in parallel with
increasing numbers of patients with noncancer diagnoses.19 Another study, focused on
decedents in nursing homes who used hospice, also found an increase in noncancer
diagnoses but a lower mean length of stay driven by increasing numbers of people who used
the benefit for ≤7 days.23 In our lower income, urban Midwest cohort with higher numbers
of nonwhite patients, noncancer diagnoses also increased over time. However, the hospice
length of stay was consistently high throughout the 10-year study period, with a mean length
of 114 days.
There are three key findings in this analysis that merit further discussion. First, although
hospice eligibility is often ascribed to a single diagnosis (eg. heart failure), these data
demonstrate significant comorbidity among older adults receiving the hospice benefit in the
nursing home. Second, although these patients have a significant burden of cognitive and
functional impairment, neither these impairments, as systematically measured by MDS
assessment, nor age are significant predictors of hospice length of stay. Third, it is difficult
to isolate nursing home hospice care as a specific targeted benefit from community-based
hospice care because patients often receive hospice care in the community before or after the
nursing home stay. In addition, many patients disenroll from hospice before death. These
patterns have important implications for any policies designed to deter or promote hospice
care in the nursing home.
In this analysis, we compared nursing home patients who received hospice for ≤180 or >180
days (ie. those who exceeded the anticipated 6-month life expectancy and remained on
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hospice). Nearly 20% of the population studied had a hospice length of stay longer than 6
months. Another recent study found that about 15% of patients had hospice stays longer than
6 months; their study focused on nursing home decedents, which may account for differing
findings.23 The only factors significantly associated with long hospice stays were enrolling
in hospice before nursing home admission and hospice primary diagnoses of failure to
thrive, dementia, and lung disease. The clinical context for a given patient is more
complicated than a single hospice diagnosis; 92% of all nursing home hospice patients had
≥3 comorbidities. The greater burden of cardiovascular disease in the ≤6-month group,
regardless of primary hospice diagnosis, may explain why some patients did not live as long
and thus had shorter hospice stays. We did not, however, find other systematic differences
based on demographic and clinical characteristics, notably race or having advanced
dementia (cognitive performance scale score = 5 or 6), between nursing home patients on
hospice ≤6 or >6 months. Hospitalization in the year before enrollment in hospice was
associated with a hospice stay of ≤6 months; patients requiring hospitalization may be sicker
and more clinically unstable. Nursing home patients are medically complex and have
functional impairments: Although these analyses identified some differences between those
who were on hospice ≤6 or >6 months, clear patterns that could reliably predict length of
stay did not emerge.
This study’s findings indicate that “nursing home hospice patients” are not a homogenous
group. The varying patterns of use across treatment settings may have implications if access
to the hospice benefit were to change in the nursing home setting. Residential nursing home
patients who enroll in hospice at the end of life represent more than half of the patients in
these analyses, but there are multiple other utilization patterns. About 12% of our nursing
home hospice cohort represented community-dwelling patients who enrolled in hospice
before admission to the nursing home, possibly because of increased care needs that could
not be managed at home. In contrast, 7% were nursing home patients who enrolled in
hospice and then transitioned into the community. These groups could be affected in
different ways if the structure of the current hospice benefit were altered, that is, if a
separate hospice benefit was developed for use in a nursing home setting. Any modifications
to the existing hospice benefit need to take into consideration transitions between care
settings and allow for such movement while maintaining hospice enrollment to
accommodate patients’ needs.
Overall, nearly 18% of nursing home patients disenrolled from hospice and more than one
third of those with hospice stays longer than 6 months disenrolled before death. About 15%
of all Medicare hospice beneficiaries disenrolled before death in 2009.15 More than half of
the patients in our cohort who disenrolled subsequently died within a year. The findings
suggest that although many patients did not fit into the less than 6 months life expectancy of
Medicare benefit, they were near the end of their lives, and thus a broader hospice benefit, or
access to nonhospice palliative care, could be appropriate. There are many potential reasons
for disenrollment from hospice. Hospice providers may choose to disenroll patients who no
longer meet the prognostic eligibility criteria of a life expectancy of ≤6 months, and patients
can choose to disenroll at any time (eg, if they decide they want curative interventions).
Nonwhite patients have been found to be more likely to disenroll from hospice24,25; in this
cohort, about 40% of the patients were nonwhite, which may help explain why our
disenrollment rates were greater. Other analyses have found that disenrollment before death
is more likely for patients with noncancer diagnoses, for whom prognosis may be less
certain.26 It is likely that patients who survive longer than 6 months on hospice and then
ultimately disenroll experience a more stable clinical course than anticipated. Increased
access to nonhospice palliative care would decrease the burden of predicting life expectancy,
which is challenging in this patient population, and place the emphasis on matching patient
goals with treatments.
Unroe et al. Page 6
J Am Med Dir Assoc. Author manuscript; available in PMC 2013 November 07.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Our study has several limitations. First, our cohort was drawn from a safety net hospital that
serves a population that is disproportionately poor, nonwhite, and characterized by high
health care costs and a large population of older adults who are dual eligible. Although our
results generalize to the growing population of older adults served by safety net providers,
our findings may differ from the experiences of other nursing home patients in Indianapolis
or nationally. With the data available in this retrospective analysis, we could not determine
many important variables that influence patterns of hospice or nursing home use, including
social support and preferences for care.
Despite the increasing use of hospice in the nursing home setting, most people who die in
nursing homes are not receiving hospice. There are also concerns that the hospice benefit is
underused in this setting,13 and unmet palliative care needs in nursing homes have been
described.4–8 Hospice use has been associated with improvement in end-of-life care in
nursing homes,9–12 and access to hospice should be preserved for these patients. Some have
advocated for a new benefit to replace hospice in nursing homes, through which Medicare
would pay nursing homes directly for providing palliative and restorative care.27 Although
this strategy has the potential advantages of directly paying the nursing home and keeping
the locus of accountability within the facility, as opposed to an outside hospice agency, there
are limitations to this approach in the current environment, including disruption in care if
patients move across settings. Targeting the appropriate population within the nursing home
would continue to present challenges, as well as significant concerns about staff turnover
and staff skill level and current training in palliative care.27
Conclusions
Access to palliative and end-of-life care in nursing homes is a critical issue for patients,
families, providers, and policymakers. Policymakers seeking to reform the use of the
hospice benefit in nursing homes should take into account the difficulty in predicting the
clinical course of patients with serious, advanced illness, varying utilization patterns and
transitions across settings that make it difficult to define a strictly “nursing home hospice”
population, and the importance of supporting multiple approaches for delivery of palliative
care in this setting.
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Fig. 1.
Primary hospice diagnoses over a 10-year period.
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Fig. 2.
Common patterns of hospice use overlapping with nursing home residence.
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Table 1
Baseline Characteristics of Study Population: Nursing Home Hospice Patients by Hospice Length of stay
Characteristics Total (N = 1452) Hospice Length of Stay P
<180 days (n= 1166) >180 days (n = 286)
Age at hospice enrollment, y, mean (SD) 81.2 (8.2) 81.2 (8.1) 80.9 (8.5) .4856
Male sex, n (%) 544 (37.5) 447 (38.3) 97 (33.9) .1664
White race, n (%) 870 (59.9) 692 (59.4) 178 (62.2) .3716
ADL impairments, mean (SD)*
  Categorical indicators 16.2 (6.4) 16.3 (6.3) 15.6 (6.6) .1120
  Binary indicators 5.0 (1.7) 5.0 (1.6) 4.8 (1.8) .1245
CPS score, mean (SD)* 2.9 (1.8) 2.9 (1.8) 2.7 (1.8) .1259
CPS score = 5 or 6, n (%)* 252 (18.2) 206 (18.6) 46 (16.6) .4326
Dual-eligible Medicaid/Medicare, n (%) 1091 (75.1) 877 (75.2) 214 (74.8) .8914
Comorbidities, n (%)
  Dementia 1091 (75.1) 874 (75.0) 217 (75.9) .7478
  Cancer 817 (56.3) 661 (56.7) 156 (54.6) .5125
  CAD 947 (65.2) 778 (66.7) 169 (59.1) .0152
  CHF 884 (60.9) 726 (62.3) 158 (55.2) .0293
  Hypertension 1306 (89.9) 1058 (90.7) 248 (86.7) .0426
  Arthritis 982 (67.6) 788 (67.6) 194 (67.8) .9353
  Diabetes 822 (56.6) 676 (58.O) 146 (51.1) .0342
  COPD 864 (59.5) 698 (59.9) 166 (58.0) .5740
  Stroke 377 (26.0) 310 (26.6) 67 (23.4) .2747
  Renal disease 63 (4.3) 56 (4.8) 7 (2.5) .0798
  Liver disease 244 (16.8) 206 (17.7) 38 (13.3) .0758
  >3 comorbidities 1374 (94.6) 11 07 (94.9) 267 (93.4) .2872
Length of stay on hospice, days, mean (SD); median 114.1 (196.0); 36 40.8 (45.7); 20 412.9 (274.9); 331 <.0001
Disenrollment before death, n (%) 258 (17.8) 161 (13.8) 97 (33.9) <.0001
On hospice before NH admittance, n (%) 208 (14.3) 125 (10.7) 83 (29.0) <.0001
Days in NH before hospice enrollment, mean (SD); median† 756.4 (968.8); 400.5 708.8 (958.0); 309 1000.3 (989.4); 836 <.0001
Long-stay NH patients (>90 days), n (%) 936 (64.5) 759 (65.1) 177 (61.9) .3100
Hospital stay in prior year to hospice, n (%) 1080 (74.4) 898 (77.0) 182 (63.6) <.0001
Primary hospice diagnosis, n (%) .0379
  Cancer 423 (29.1) 351 (30.1) 72 (25.2)
  Dementia 321 (22.1) 249 (21.4) 72 (25.2)
  Failure to thrive 145 (10.0) 108 (9.3) 37 (12.9)
  Heart disease 126 (8.7) 104 (8.9) 22 (7.7)
  Lung disease 116 (8.O) 86 (7.4) 30 (10.5)
  Other 321 (22.1) 268 (23.0) 53 (18.5)
Hospice admission year, n (%) .6586
  1999–2000 83 (5.7) 71 (6.1) 12 (4.2)
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Characteristics Total (N = 1452) Hospice Length of Stay P
<180 days (n= 1166) >180 days (n = 286)
  2001–2002 180 (12.4) 142 (12.2) 38 (13.3)
  2003–2004 331 (22.8) 270 (23.2) 61 (21.3)
  2005–2006 423 (29.1) 339 (29.1) 84 (29.4)
  2007–2008 435 (30.0) 344 (29.5) 91 (31.8)
χ2 test was used to make comparisons on categorical variables; t test was used for continuous variables.
ADL, activities of daily living; CAD, coronary artery disease; CHF, congestive heart failure; CPS, cognitive performance scale; NH, nursing home.
*Seventy cases were missing on CPS; 148 were missing on ADL scale.
†
Two hundred and eight cases where subject was on hospice before NH admission were excluded from calculation.
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